Evidence map›Paper›PMID 36168245›Full record

ArticleYonsei medical journal2022

Tranexamic Acid and Intraoperative and Postoperative Accumulative Bleeding in Elective Degenerative Spine Surgery.

Mahmoud Abdou, Ji-Won Kwon, Hye Jin Kim, Bora Lee, Yong Seon Choi, Seong-Hwan Moon, Byung Ho Lee

Abstract read
In one paragraph

Article in Yonsei medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Validated intraoperative bleeding severity scale (VIBe) for hemostasis assessment in lumbar spinal fusion: a prospective, randomized controlled trial.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mahmoud AbdouDepartment of Orthopedic Surgery, Fayoum University College of Medicine, Fayoum, Egypt.ORCID https://orcid.org/0000-0002-0797-9579
Ji-Won KwonDepartment of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4880-5310
Hye Jin KimDepartment of Anesthesia, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3452-477X
Bora LeeDepartment of Anesthesia, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1162-9803
Yong Seon ChoiDepartment of Anesthesia, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-9030-4854
Seong-Hwan MoonDepartment of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5165-1159
Byung Ho LeeDepartment of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea. bhlee96@yuhs.ac.ORCID https://orcid.org/0000-0001-7235-4981

Funding

Ministry of Trade, Industry and Energy P092400007
6 · The paper itself

Abstract

purposeSpinal surgeries are often associated with a high incidence of perioperative blood loss, which poses several complications. Much current research focuses on the importance of antifibrinolytic drugs during spinal surgeries to reduce blood loss, which can also reduce the risk of the need for blood transfusions. We evaluated the effects of prophylactic, low-dose tranexamic acid (TXA) in spinal fusion surgeries on blood loss, blood transfusions, and associated complications. MATERIALS AND

methodsTXA was administered to 90 patients at a constant infusion rate of 10 mg/kg for 20 minutes after anesthesia induction, followed by a maintenance dose of 1 mg/kg/h until the end of the operation. An additional 91 patients were included as controls.

resultsThere were no significant differences between the study groups in terms of intraoperative blood loss, which was 500 mL for both groups (

conclusionWe confirmed that low dose TXA has no effect on intraoperative blood loss volume or blood transfusion requirements and that it can significantly reduce the need for postoperative blood transfusions.

Indexed as

Antifibrinolytic AgentsTranexamic AcidBlood Loss, SurgicalBlood TransfusionElective Surgical ProceduresHumansAntifibrinolytic AgentsTranexamic AcidBlood lossblood transfusionintraoperativePLIFpostoperativetranexamic acid

Identifiers

PMID36168245
PMCPMC9520043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.